OpenBilldrug price receipt

NADAC week of 2026-10-14

COLESEVELAM 625 MG TABLET

For 30 tablets

Pharmacies pay

$7.85 filed

30 × $0.26171 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$31.22 filed

30 × $1.04079 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

4.0× estimated

Medicare paid 4.0× what pharmacies pay.

Part D averages every strength and form sold under “Colesevelam HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$14.03 estimated

$7.85 + $1.18 (15%) + $5.00 fee per fill = $14.03

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

COLESEVELAM 625 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “colesevelam hydrochloride” and “colesevelam hcl”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Amneal Pharmaceuticals of New York LLC, Cranbury Pharmaceuticals, LLC and Dr.Reddys Laboratories Inc.

FDA’s Established Pharmacologic Class for it is Bile Acid Sequestrant.

The NADAC file of 2026-10-14 prices it under 10 NDCs (National Drug Codes); the FDA directory lists 8 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $7.85 for 30 tablets (30 × $0.26171 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The 7 labelers

LabelerNDCsPharmacies pay per unit
Bionpharma Inc.2$0.26171 per EA filed
American Health Packaging1$0.26171 per EA filed
Amneal Pharmaceuticals of New York LLC1$0.26171 per EA filed
Ascend Laboratories, LLC1$0.26171 per EA filed
Cranbury Pharmaceuticals, LLC1$0.26171 per EA filed
Dr.Reddys Laboratories Inc1$0.26171 per EA filed
Glenmark Pharmaceuticals Inc., USA1$0.26171 per EA filed
Not listed as a package in the FDA directory2$0.26171 per EA filed
All 10 NDCs, with labeler and price
  • 00115-1320-19 · Amneal Pharmaceuticals of New York LLC · $0.26171 per EA · eff. 2026-09-23 filed
  • 00713-0936-81 · not listed as a package in the FDA directory · $0.26171 per EA · eff. 2026-09-23 filed
  • 27808-0190-01 · Cranbury Pharmaceuticals, LLC · $0.26171 per EA · eff. 2026-09-23 filed
  • 43598-0230-18 · Dr.Reddys Laboratories Inc · $0.26171 per EA · eff. 2026-09-23 filed
  • 60687-0385-25 · American Health Packaging · $0.26171 per EA · eff. 2026-09-23 filed
  • 60687-0385-95 · not listed as a package in the FDA directory · $0.26171 per EA · eff. 2026-09-23 filed
  • 67877-0506-51 · Ascend Laboratories, LLC · $0.26171 per EA · eff. 2026-09-23 filed
  • 68462-0433-18 · Glenmark Pharmaceuticals Inc., USA · $0.26171 per EA · eff. 2026-09-23 filed
  • 69452-0158-25 · Bionpharma Inc. · $0.26171 per EA · eff. 2026-09-23 filed
  • 69452-0493-25 · Bionpharma Inc. · $0.26171 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

1 other product in the NADAC file shares an FDA nonproprietary name with COLESEVELAM 625 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
COLESEVELAM 625 MG TABLET this page
generic · tablet, film coated / tablet
$0.26171 per EA filed
eff. 2026-09-23
$1.04079 per EA filed
Part D 2024 average
COLESEVELAM HCL 3.75 G PACKET
generic · powder, for suspension
$2.70422 per EA filed
eff. 2026-09-23
$1.04079 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 10 NDCs’ NADAC prices is $0.26171 per EA filed.

Of the 5 other products in FDA’s Bile Acid Sequestrant class priced per EA, 5 have a higher middle NADAC price and 0 a lower one. The one in the middle is PREVALITE PACKET, at $0.83267 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $31.22 for 30 tablets, at an average of $1.04079 per EA in 2024 (2024-01-01 to 2024-12-31) for “Colesevelam HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 262,604 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for COLESEVELAM 625 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Colesevelam HCl / Colesevelam HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.